Study of ANAVEX2-73 in Patients With Rett Syndrome

NCT03758924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: ANAVEX2-73
DRUG: Placebo

Sponsor

Anavex Life Sciences Corp.

Collaborators

[object Object]